2-208407071-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005048.4(PTH2R):c.28G>A(p.Val10Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000805 in 1,395,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005048.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTH2R | NM_005048.4 | c.28G>A | p.Val10Ile | missense_variant | 1/13 | ENST00000272847.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTH2R | ENST00000272847.7 | c.28G>A | p.Val10Ile | missense_variant | 1/13 | 1 | NM_005048.4 | P1 | |
PTH2R | ENST00000617735.4 | c.-258-21130G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000574 AC: 76AN: 132422Hom.: 0 AF XY: 0.000432 AC XY: 31AN XY: 71830
GnomAD4 exome AF: 0.000836 AC: 1040AN: 1243606Hom.: 0 Cov.: 30 AF XY: 0.000833 AC XY: 505AN XY: 606232
GnomAD4 genome AF: 0.000552 AC: 84AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.28G>A (p.V10I) alteration is located in exon 1 (coding exon 1) of the PTH2R gene. This alteration results from a G to A substitution at nucleotide position 28, causing the valine (V) at amino acid position 10 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at